The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| OBSEVA SA | COM | H5861P103 | 2,528 | 1,570,000 | SH | SOLE | 1 | 1,570,000 | 0 | 0 | |
| VAXCYTE INC | COM | 92243G108 | 41,071 | 1,887,478 | SH | SOLE | 1 | 1,887,478 | 0 | 0 | |
| MERUS N V | COM | N5749R100 | 36,224 | 1,600,000 | SH | SOLE | 1 | 1,600,000 | 0 | 0 | |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 20,684 | 2,450,679 | SH | SOLE | 1 | 0 | 0 | 0 | |
| CHECKMATE PHARMACEUTICALS IN | COM | 162818108 | 0 | 0 | SH | SOLE | 1 | 0 | 0 | 0 | |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 97,221 | 19,963,157 | SH | SOLE | 1 | 19,963,157 | 0 | 0 | |
| AURA BIOSCIENCES INC | COM | 05153U107 | 43,075 | 3,039,892 | SH | SOLE | 1 | 3,039,892 | 0 | 0 | |